Find Academic Supervisors

Carlos Salomon Gallo is a Professor and NHMRC Investigator Fellow (EL2) at The University of Queensland's Centre for Clinical Research, affiliated with the School of Biomedical Sciences. He directs the Centre for Extracellular Vesicle Nanomedicine and leads the Exosome Biology Laboratory. A globally recognized key opinion leader in extracellular vesicles (ranked 3rd worldwide by Expertscape), his research focuses on EV biology for diagnostic and therapeutic applications in ovarian cancer, gestational diabetes, preeclampsia, and other obstetrical syndromes. His research integrates proteomics (SWATH-MS), miRNA analysis, and advanced isolation techniques to develop liquid biopsies. Core interests include: EV biomarker discovery and validation for early disease detection. Mechanisms of EV-mediated signaling in metabolic and oncological pathologies. Engineering EVs for targeted drug delivery and CRISPR-Cas therapeutics. Clinical translation of EV-based diagnostics (IVDs) and therapeutics. Analysis of his recent articles reveals a dominant focus on EV profiling in pregnancy complications (gestational diabetes, preeclampsia) and oncology (ovarian cancer), utilizing multi-omics approaches. Key trends include developing high-sensitivity EV biosensors, understanding hypoxia-induced EV signaling, and exploring 3D models for EV research. He has received significant recognition, including: NHMRC Emerging Leadership Fellow NHMRC Investigator Fellow (EL2) He leads the Exosome Biology Laboratory and the UQ Centre for Extracellular Vesicle Nanomedicine, fostering cross-disciplinary collaboration. His work involves extensive national and international partnerships, evidenced by leadership roles in the Centre for Clinical Diagnostics and over 20 invited international talks in 5 years. He actively mentors HDR students and contributes to global EV research standards (MISEV2023).

• Extracellular Vesicles
• Biomarker Discovery
• Exosome Biology
• +7 more

Dr. Md Reduanul Hossain is a Research Fellow at the University of Newcastle's School of Medicine and Public Health, specializing in reproductive medicine within the Mothers and Babies Research Program. He holds a PhD in Reproductive Medicine (Newcastle) and dual Master's degrees (MSc Pharmaceutical Science, MPhil) from the University of Greenwich, UK. His research integrates reproductive biology, nanomedicine, and pharmacology, focusing on: Developing uterine-targeted nanoparticle systems for preterm birth prevention Identifying synergistic tocolytic drug combinations using human tissue models Investigating placental exosomes in uterine contractility Creating precision medicine approaches for gynaecological cancers via patient-derived xenografts/organoids Publications emphasize tocolytic efficacy , nanoparticle drug delivery , and myometrial physiology , with recent work advancing quantitative methods for contraction analysis and low-dose combination therapies. Awards & Grants: Animal Welfare Award (2023) UNRSC/UNIPRS Scholarships (2017) $78,726 in active funding for placental biopsy/exosome projects (2025–2026) He mentors students through Honours/Master's projects in reproductive sciences and molecular biology, though no named advisees are documented.

• Reproductive Medicine
• Cancer Cell Biology
• Nanomedicine
• +5 more

Nikhilesh Bappoo is an Adjunct Research Fellow at the UWA Medical School, affiliated with the UWA Centre for Medical Research and the Harry Perkins Institute of Medical Research. He holds a Doctor of Philosophy (PhD) student status alongside a Master of Professional Engineering (2018) and a Bachelor of Philosophy (Hons) (2017), both from the University of Western Australia. His research focuses on placental vascular structure and hemodynamics, fetal growth restriction, and computational modeling of vascular diseases such as abdominal aortic aneurysms. Key areas include understanding how hemodynamic factors like shear stress influence placental function and aneurysm progression. He employs multidisciplinary approaches blending biomechanics, medical imaging, and computational simulations. Notable awards include the Materialise Mimics Innovation Award (2017), ASME Best Student Paper (2018), and a Convocation Postgraduate Research Travel Award (2019). His work contributes to UN Sustainable Development Goals related to good health and well-being. Research outputs span vascular network modeling, aneurysm biomechanics, and placental oxygen diffusion. Collaborations involve institutions globally, with recent studies exploring rare vascular conditions like pancreaticoduodenal artery aneurysms.

• Biomedical Engineering
• Placental Biology
• Vascular Physiology
• +4 more

Professor Janna Morrison is a Professor of Physiology at the University of South Australia within the Clinical & Health Sciences school. She is based at the City West Campus (HB5-28) and serves as a Research Degree Supervisor. Her research primarily focuses on fetal physiology and developmental origins of health and disease, with particular emphasis on placental function, cardiovascular development, and respiratory systems in animal models. Dr. Morrison's research interests span fetal physiology, placental development, developmental origins of health and disease, cardiovascular development, respiratory development, and pregnancy complications. Her work frequently utilizes sheep models to investigate how maternal conditions affect fetal development and how these developmental changes may program health outcomes later in life. She has made significant contributions to understanding intrauterine growth restriction, fetal cardiac development, and the pulmonary surfactant system. Analysis of her recent publications reveals a strong focus on using advanced imaging techniques like MRI to assess maternal-fetal physiology, investigating sex-specific responses to developmental challenges, and exploring interventions that might mitigate adverse programming effects. Her research bridges basic science with potential clinical applications in perinatal medicine. Professor Morrison has received funding from major Australian research councils including ARC and NHMRC grants (DP190102263, DP220103289, 511340). She leads the Early Origins of Adult Health Research Group within the Health and Biomedical Innovation division at UniSA. Her laboratory work frequently involves collaborations with the South Australian Health and Medical Research Institute (SAHMRI) and utilizes sophisticated techniques including cardiac MRI feature tracking, redox monitoring systems, and molecular analysis of tissue samples from animal models.

• Fetal Physiology
• Placental Development
• Developmental Origins of Health and Disease
• +5 more

Barry Doyle is an Adjunct Associate Professor in the School of Engineering at the University of Western Australia and the Lab Head of the Vascular Engineering Laboratory (VascLab) at the Harry Perkins Institute of Medical Research. He holds a BEng and PhD in Biomedical Engineering from the University of Limerick. His research focuses on cardiovascular health and disease, leveraging cutting-edge engineering techniques, including 3D bioprinting, biomaterials, and computational fluid dynamics. He has secured over $11 million in research funding and co-developed the Biomedical Engineering program at UWA. Notable awards include the Western Australian Innovator of the Year (2021) and three Mimics Innovation Awards (2009, 2017, 2018). Education: BEng (2005), PhD (2009), both in Biomedical Engineering, University of Limerick. Affiliations: Honorary Fellow at the British Heart Foundation Centre, University of Edinburgh; CTO at FloMatrix. His research interests span cardiovascular biomechanics, soft tissue modeling, and medical device development. He has authored over 140 publications and edited several textbooks, including Cardiovascular Biomechanics (Springer, 2017). His work addresses diseases like aortic aneurysms, coronary artery disease, and placental vascular dysfunction. His lab, VascLab, focuses on translating engineering innovations into clinical applications, such as novel heart valves and vascular implants. He has led projects funded by NHMRC, ARC, and industry partners. Awards: Western Australian Innovator of the Year 2021 UHU Seed Funding Grant 2019 Three Mimics Innovation Awards Grants & Funding: Over $11M as lead/co-lead in projects like the ARC Training Centre for Personalised Therapeutics Technologies. Doyle is an active editor for journals such as Medical Engineering & Physics and European Journal of Vascular and Endovascular Surgery , and a reviewer for national/international funding bodies.

• Biomedical Engineering
• Cardiovascular Biomechanics
• Computational Fluid Dynamics
• +6 more

Dr Katrina Mirabito Colafella is a NHMRC CJ Martin Fellow and Future Leader at the Cardiovascular Disease Program , Monash Biomedicine Discovery Institute , Monash University . She completed her PhD in 2015 under Professor Kate Denton and held postdoctoral fellowships at Erasmus Medical Centre, The Netherlands, and Monash University. Research Interests Hypertension and Cardiovascular Disease Renin-Angiotensin System Sex-Specific Risk Factors (Pregnancy, Menopause) Cardio-Oncology Vascular Biology and Kidney Function Article Trends (2025-2021): Recent publications emphasize sex differences in hypertension, dietary interventions for blood pressure regulation, and cardiovascular toxicity of cancer therapies. Collaborative work spans renin-angiotensin system modulation, microbiome-cardiovascular interactions, and RNA-based therapeutics. Scientific Awards American Journal of Physiology: Renal Physiology Paper of the Year 2014 Best Early Career Oral Prize 2017 CJ Martin Biomedical Fellowship 2015 Stephanie Watts Career Development Award Finalist 2018 Grants & Collaborations : Lead Principal Investigator for projects like "Sex-differences in cellular aging" and "MediBeacon Transdermal Mini Fluorophore Monitors" , with collaborations across Australia, Netherlands, and international institutions.

• Cardiovascular Disease
• Hypertension
• Renin Angiotensin System
• +4 more

Professor David Evans is a Group Leader and Director of the Centre for Population and Disease Genomics at the Institute for Molecular Bioscience, University of Queensland. His research focuses on dissecting genetic and environmental influences on complex traits like osteoporosis, sepsis, and handedness using advanced statistical genetics methods. He leads international consortia such as EGG and GEFOS, and collaborates with global cohorts including the UK Biobank and Norwegian MOBA/HUNT studies. Key projects include large-scale GWAS analyses and Mendelian randomization studies to investigate causal relationships in genetic epidemiology. Evans’ group develops statistical tools like DINGO software for genetic analysis and LDHub for estimating genetic correlations. They have discovered 41 genetic loci associated with left-handedness and pioneered studies linking developmental origins (DOHaD) with adult health outcomes. His team includes 8 current PhD students and postdoctoral researchers, supported by extensive collaborations with institutions like University of Bristol and McGill University. Research interests span intergenerational effects of maternal traits, skeletal biology, and sepsis genetics. Notable achievements include leading one of the world’s largest sepsis molecular studies and contributing to drug target identification for osteoporosis through zebrafish models. Evans’ work bridges statistical innovation with clinical relevance, addressing public health challenges via genomic data integration.

• Genetic Epidemiology
• Statistical Genetics
• Mendelian Randomization
• +5 more

Dr. David Coall is a Senior Lecturer at the School of Medical and Health Sciences, Edith Cowan University, with a multidisciplinary focus on intergenerational health and evolutionary medicine. He serves as Biomedical Science Course Coordinator, Human Biology Major/Minor Coordinator, and Research Lead for the Grandparent and Intergenerational Health Solutions Research Group. Senior Lecturer, ECU (2012–present) Visiting Professor, University of Turku (2022–present) Adjunct Research Fellow, UWA (2012–2018) His research examines intergenerational health dynamics, including grandparental investment, prenatal environmental influences, reproductive strategies, and suicide prevention. His work bridges evolutionary theory with public health applications, particularly for marginalized populations like custodial grandparents and Aboriginal communities. Recent publications (2024) address placental biology, grandparent-facilitated child physical activity, and mental health safe spaces. Grants include $399k from LotteryWest (2017–2023) and $75k from the Department of Mines (2023–2024). Elsevier’s Atlas Award (2017) for caregiving mortality research Coordinated 8+ student theses on placental health and intergenerational care He actively contributes to policy translation for low-resource families and leads interdisciplinary projects connecting biomedical science with social determinants of health.

• Intergenerational Health
• Evolutionary Medicine
• Reproductive Biology
• +5 more

Patricia Green is an Assistant Professor in the Faculty of Health Sciences & Medicine at Bond University. She holds a Master's in Health Care Research from Griffith University and a Master's in Clinical Practice from Western Sydney University. Her research focuses on simulation-based education, particularly in developing quality assurance frameworks for simulated participant programs. She contributes to projects establishing benchmarks for healthcare training and core clinical competencies for medical students.

• Medical Simulation
• Clinical Assessment
• Healthcare Education
• +2 more

Professor Jose Polo is the inaugural Director of the Adelaide Centre for Epigenetics (ACE) and group leader at the South Australian Immunogenomics Cancer Institute (SAiGENCI) at the University of Adelaide. He holds appointments in the Faculty of Health and Medical Sciences and School of Biomedicine. His research focuses on epigenetic mechanisms governing cell identity, reprogramming, and cancer. Key achievements include co-founding Mogrify Ltd to translate reprogramming technologies into therapies and pioneering induced trophoblast stem cell (iTSC) research. Education: Biochemistry degree from Buenos Aires University, PhD from Albert Einstein College of Medicine (2008). Postdoctoral training at Harvard Stem Cell Institute (2008–2011). Established independent research groups at Monash University (2011–2021) and now at the University of Adelaide since 2021. Research Interests: Epigenetic regulation of pluripotency, cellular reprogramming, cancer initiation/progression, and synthetic cell biology. Techniques include stem cell models, genomic approaches (ChIP, CUT&RUN, single-cell omics), and novel methods like TINC for protein complex analysis. Grants & Awards: Over 15 grants including NHMRC, ARC, and industry partnerships. Recognitions include the Metcalf Award, Victorian Tall Poppy Award, and Scrip Innovation Award. Advising & Labs: Supervised over 20 PhD/Masters students and postdocs. Current lab projects include iBlastoid development, iTSC models for placental research, and epigenetic mechanisms in cancer.

• Epigenetics
• Stem Cell Biology
• Cell Reprogramming
• +5 more

Eva Dimitriadis is an Adjunct Associate Professor at Monash University's Department of Anatomy and Developmental Biology and a Research Group Head at the Centre for Reproductive Health within the Hudson Institute of Medical Research . NHMRC Senior Research Fellow Lecturer in Reproductive Biology at Monash University Education: BSc (Melbourne) PhD (Trinity College Dublin) Postdoctoral studies (University of Dublin) Research Focus: Dr. Dimitriadis investigates infertility , endometrial-trophoblast interactions , and the microRNA regulation of implantation. Her work spans non-invasive biomarkers , targeted delivery systems , and pre-clinical trials for endometrial cancer and non-hormonal contraception that prevents pregnancy and sexually transmitted diseases. Scientific Outputs: Recent work focuses on miR-124-3p in endometrial receptivity, IL-11 in preeclampsia , and radiotherapy-induced uterine damage . These studies intersect reproductive immunology , placentation , and translational medicine . Scientific Awards: NHMRC Senior Research Fellow Editorial recognition in Science and PNAS for 2007 work Collaborations: International partnerships with University of Tokyo , Karolinska Institutet , and institutions like Monash IVF , Walter Eliza Hall Institute , and Commonwealth Serum Laboratories .

• Infertility
• Endometrial receptivity
• Embryo implantation
• +7 more

Professor Kirsty Pringle serves as the Assistant Dean for Equity, Diversity and Inclusion in the College of Health, Medicine and Wellbeing at the University of Newcastle. She is a teaching/research academic in the School of Biomedical Sciences and Pharmacy, where she leads the Placental Biology and Pregnancy Research group within the Women's Health Program at the Hunter Medical Research Institute. Her work focuses on improving outcomes for mothers and their babies, particularly in Australian Aboriginal communities through the Gomeroi Gaaynggal Study. PhD in obstetrics and gynaecology at the University of Adelaide (2003) Bachelor of Science (Honours) from the University of Adelaide Professor Pringle's research spans placental biology, Indigenous maternal health, and the renin-angiotensin system's role in pregnancy. She investigates how maternal exposures program fetal development, particularly focusing on kidney and cardiovascular health outcomes. Her work with the Gomeroi Gaaynggal Study examines over 200 Indigenous mothers and infants from Tamworth, Walgett, and Newcastle to identify factors affecting pregnancy outcomes. She also explores repurposing hypertension medications for endometrial cancer treatment and examines sex differences in pregnancy complications. Her extensive publication record demonstrates a strong focus on understanding pregnancy complications, particularly preeclampsia, fetal growth restriction, and their long-term health consequences. A significant portion of her work centers on Indigenous Australian health outcomes, examining how maternal factors influence fetal kidney development. Her recent research has increasingly focused on the renin-angiotensin system's role in placental function, with implications for potential therapeutic interventions targeting ACE2 and the (pro)renin receptor. 2024 Society for Reproductive Biology (SRB) Award for Excellence in Reproductive Biology Professor Pringle serves as Course Coordinator for HUBS3511 Human Reproduction and Pregnancy (2022-2025). She leads the Gomeroi Gaaynggal longitudinal cohort study and collaborates extensively with researchers including Dr. Kym Rae, Laureate Professor Roger Smith, and Emeritus Professor Eugenie Lumbers. Her research has secured funding for investigations into placental biology, Indigenous maternal health, and the renin-angiotensin system's role in pregnancy complications. As leader of the Placental Biology and Pregnancy Research group at the Hunter Medical Research Institute, Professor Pringle oversees a multidisciplinary team focused on understanding placental development and pregnancy complications. Her Gomeroi Gaaynggal Study involves close collaboration with Indigenous communities to translate research findings into clinical practice, particularly seeking ways to identify and address underlying health issues before they become clinically apparent.

• Pregnancy and women's reproductive health
• Placental biology
• Indigenous maternal health
• +7 more

Nik Bappoo is an Adjunct Research Fellow at The University of Western Australia Medical School and the UWA Centre for Medical Research (affiliated with the Harry Perkins Institute of Medical Research). Currently completing a Doctor of Philosophy, Bappoo's research focuses on the intersection of biomechanics and reproductive medicine, particularly examining placental and vascular dynamics in both fetal development and adult vascular conditions. Education: Bachelor of Philosophy (Hons), The University of Western Australia (awarded March 3, 2017) Master of Professional Engineering, The University of Western Australia (awarded July 25, 2018) Bappoo's research primarily investigates hemodynamic principles in two major areas: placental blood flow in fetal development and abdominal aortic aneurysm mechanics. Their work employs advanced computational modeling techniques to understand vascular networks, with particular focus on how blood flow characteristics affect both fetal growth restriction and aneurysm progression. The research integrates engineering principles with clinical medicine to develop predictive models that could improve patient outcomes. Analysis of Bappoo's publication record reveals a strong focus on applying biomechanical principles to both reproductive and vascular medicine. The research demonstrates expertise in computational fluid dynamics applied to complex vascular networks, with publications spanning from fundamental hemodynamic studies in rat models to clinical applications in human vascular disease. The work consistently connects engineering analysis with clinical outcomes, showing translational potential in both obstetrics and vascular surgery. Scientific Awards: Materialise Mimics Innovation Award – first prize for the Asia-Pacific region (July 26, 2017) ASME (The American Society of Mechanical Engineers) Best Student Paper - Second Prize (2018) Convocation Postgraduate Research Travel Award (2019) Bappoo has been actively involved in collaborative research projects, working with multiple investigators across disciplines including engineering, obstetrics, and vascular surgery. Their media presence indicates successful communication of complex research to broader audiences, with coverage in outlets highlighting the significance of micro-CT imaging for understanding placental blood flow and breakthroughs in fetal medicine. The research has garnered attention on academic social networks and among researchers in the field. Bappoo's work is conducted within the UWA Centre for Medical Research (affiliated with the Harry Perkins Institute of Medical Research), leveraging advanced imaging and computational facilities to create detailed models of vascular networks. The research team appears to integrate expertise from mechanical engineering, medical imaging, and clinical medicine to address complex questions in both fetal development and vascular disease.

• Placenta
• Vascularity
• Hemodynamics
• +5 more

Dr Emma Louise Sweeney is a Senior Research Fellow at the University of Queensland’s Centre for Clinical Research, Faculty of Health, Medicine and Behavioural Sciences. She leads a translational research programme that bridges molecular microbiology and clinical diagnostics to combat antimicrobial resistance in sexually transmitted infections and perinatal pathogens. Education Bachelor of Applied Science (QUT) Bachelor (Honours) of Applied Science (QUT) Doctor of Philosophy (QUT) Research Focus Her laboratory investigates Mycoplasma genitalium , Neisseria gonorrhoeae , Ureaplasma spp. and cytomegalovirus with the overarching goal of developing resistance-guided, precision diagnostics that inform individualised therapy. Key themes include: Molecular mechanisms of macrolide and fluoroquinolone resistance Next-generation point-of-care assays for STI clinics Placental and neonatal microbiome interactions influencing preterm birth CMV antiviral resistance in immunocompromised children Publication Trends Between 2015 and 2025 Emma has published 48 works spanning high-impact journals such as The Lancet Microbe , Nature Microbiology , Clinical Infectious Diseases , Journal of Clinical Microbiology and Journal of Infectious Diseases . Recent outputs emphasise systematic reviews of global AMR trends, in-vivo murine models of genital infection, and real-world evaluation of commercial molecular assays. Funding & Grants 2023–2025 NHMRC Ideas Grant – Enhanced HHV-6 diagnostics in children 2020–2023 Children’s Hospital Foundation – CMV resistance-guided therapy in HSCT 2019–2022 ASHM Grant – Precision public health for syphilis in Queensland 2018–2020 Pathology Queensland – M. genitalium AMR diagnostics Supervision & Mentoring Emma is currently available for HDR supervision and mentors three active PhD projects. She has successfully graduated one PhD student (2025) whose thesis developed an integrated molecular pathway for CMV management in paediatric transplant recipients.

• Molecular microbiology
• Antimicrobial resistance
• Sexually transmitted infections
• +5 more

Associate Professor Paul Dawson is a leading researcher at the University of Queensland (UQ) and Mater Research Institute . He serves as Director of Higher Degree Research and Head of Education within the Faculty of Health, Medicine and Behavioural Sciences , where his Neurodevelopmental Research Group investigates cerebral palsy , autism spectrum disorders , and nutrient sulfate biology in preterm infants. University of New England (BSc Hons) University of Queensland (PhD) His research spans molecular genetics, clinical biochemistry, and translational medicine, with a focus on sulfate transporters (SLC13A1/SLC13A4) and their role in neurological development . Key collaborations include the Queensland Brain Institute and Cerebral Palsy Alliance . Recent publications highlight his expertise in sulfate measurement methodologies (2024 NATA-approved assays), machine learning for movement classification (2024), and SLC13A1 genetic variants in skeletal dysplasia (2025). Over the past 15 years, his work has appeared in journals like Frontiers in Cellular and Infection Microbiology , Genetics in Medicine , and PLoS Pathogens . 2016 Simon & Nell George Award ($10,000) Recipient of NHMRC IDEAS Grant (2023-2025) As a principal advisor, he has guided 12 PhD/MPhil students and 3 Master's candidates, including studies on sulfate therapy for cerebral palsy and genetic causes of intellectual disability . His laboratory collaborates with Queensland Brain Institute and Royal Brisbane and Women’s Hospital , supported by over $1.5M in competitive grants.

• Neurodevelopmental Disorders
• Cerebral Palsy
• Autism Spectrum Disorders
• +3 more